Cavernous Lymphangioma Overview

Save information for later
Sign Up

Learn About Cavernous Lymphangioma

What is the definition of Cavernous Lymphangioma?
Cavernous lymphangiomas are large, irregular spaces in the lymphatic vascular system that involve the skin and subcutaneous tissues. Cavernous lymphangioma is often referred to as cystic lymphangioma They are non-cancerous fluid filled cysts that are found in vessels that make up the lymphatic system. The lymphatic system consists a network of vessels that carry a fluid called lymph throughout the body. It works to keep fluid levels in the body in balance, and along with the immune system, helps to fight infection. It is estimated that lymphangiomas occur in about 1 in 4,000 births. They can affect nearly any part of the body, They are most common on the head or neck area, but can occur in other parts of the body. Most lymphangiomas are congenital and are observed at birth while 90 percent will be appear by age two.
What are the alternative names for Cavernous Lymphangioma?
Cystic lymphangioma, cystic hygroma, lymphangioma cavernosum
What are the causes of Cavernous Lymphangioma?
Cystic lymphangiomas or cavernous lymphangiomas are congenital and are often seen at birth. Their presence can be observed visually and confirmed through an MRI, CT scan or ultrasound scan. In most cases cysts appear by age two. They occur when lymphatic vessels become backed up with lymph fluid and cause pooling and swelling in tissues of the body.
What are the symptoms of Cavernous Lymphangioma?
Cavernous lymphangiomas and cystic lymphangiomas are generally classified by the size of the cysts and legions. Areas larger than two centimeters are considered macrocystic and commonly referred to as cavernous lymphangiomas. They appear as bluish-reddish, spongy masses with defined edges. Lymphangiomas are smaller than two centimeters are considered microcystic. They tend to grow in clusters and appear as tiny blisters without defined edges.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Cavernous Lymphangioma?
Surgery is an option to removes cysts that are not near organs or nerves. Surgical excision is common for superficial lesions close to the skin's surface, while sclerotherapy is used to treat deeper lesions. Sclerotherapy is a procedure that involves injecting a chemical directly into the cyst to shrink it. Laser therapy ablation is another treatment option, and uses a laser to destroy the cyst. Complete removal of cysts is recommended to prevent recurrence.
Who are the top Cavernous Lymphangioma Local Doctors?
Elite in Cavernous Lymphangioma
Chih-ping P. Chen
Elite in Cavernous Lymphangioma
Chih-ping P. Chen
92, Chung Shan North Road, 
TPQ, TW 

Chih-ping Chen practices in Taiwan. Chen is rated as an Elite expert by MediFind in the treatment of Cavernous Lymphangioma. Their top areas of expertise are Trisomy 14 Mosaicism, Trisomy 18, Hygroma Cervical, and Mosaic Trisomy 8.

Elite in Cavernous Lymphangioma
Michio Ozeki
Elite in Cavernous Lymphangioma
Michio Ozeki
Gifu-shi, JP 

Michio Ozeki practices in Gifu-shi, Japan. Mr. Ozeki is rated as an Elite expert by MediFind in the treatment of Cavernous Lymphangioma. His top areas of expertise are Gorham's Disease, Skeletal-Extraskeletal Angiomatosis, Lymphangiomatosis, Cavernous Lymphangioma, and Bone Marrow Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Thomas A. Knipe
Experienced in Cavernous Lymphangioma
Dr. Thomas A. Knipe
Otolaryngology | Pediatric Otolaryngology
Experienced in Cavernous Lymphangioma
Dr. Thomas A. Knipe
Otolaryngology | Pediatric Otolaryngology

Proliance Surgeons

1231 116th Ave NE #915, 
Bellevue, WA 
425-454-3938
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas A. Knipe, MD, is a board-certified surgeon specializing in the medical and surgical treatment of adult and pediatric disorders of the head and neck. While practicing all aspects of otolaryngology, he has a special interest in sinus, sleep and breathing disorders and tumors of the head and neck. He is trained in advanced surgery of the sinuses and skull base to bring his patients safe and proven treatments for complex tumors of the skull base and more common sinus and breathing limitations alike. He treats patients with benign and malignant tumors of the head and neck including thyroid, parathyroid and salivary glands and is trained in salivary gland-saving endoscopic techniques to remove salivary stones. In his practice, he takes great care to educate his patients and apply his medical expertise to partner with and guide each one through important medical decisions.He is committed to serving the world’s poor and underserved through medical and surgical mission work. He travels overseas to perform surgical repair for children and adults with cleft lip and palate, thyroid disease and benign and malignant disorders of the head and neck.A native of the Seattle area, Dr. Knipe takes the Northwest’s healthy and active lifestyle to heart. He is an avid runner and works hard to keep up with his wife and two daughters. He also enjoys hiking, fishing and competing in ultimate Frisbee. Dr. Knipe is rated as an Experienced provider by MediFind in the treatment of Cavernous Lymphangioma. His top areas of expertise are Laryngitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Trachoma, Perichondritis, and Tissue Biopsy.

View All Doctors
What is the outlook (prognosis) for Cavernous Lymphangioma?
Lymphangiomas generally do not cause health problems and most the treatments are very effective. Many cysts can be shrunken or completely removed. Most patients recover without any complications. Repeat treatments may needed, however, since lymphangiomas can recur.
What are the latest Cavernous Lymphangioma Clinical Trials?
A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)
A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)
Enrollment Status: Recruiting
Publish Date: April 13, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: Recent studies have demonstrated that growth of vascular malformations can be driven by genetic variants in one of 2 signalling pathways. Targeted drugs specific to these pathways have been developed and shown to be effective in treating cancer. This study will describe the effectiveness of (i) 48 weeks of alpelisib therapy for participants with slow-flow vascular malformations and a gene mutation...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Prospective and Retrospective Clinical Study of Lymphatic Malformations: Institution of an Italian REGistry of Lymphatic Malformations and of a Biobank for Biological Sample Collection
Prospective and Retrospective Clinical Study of Lymphatic Malformations: Institution of an Italian REGistry of Lymphatic Malformations and of a Biobank for Biological Sample Collection
Enrollment Status: Recruiting
Publish Date: March 25, 2025
Intervention Type: Genetic
Study Phase: Not Applicable

Summary: Lymphatic malformations (ML), are benign non-neoplastic, rare, resulting from an embryologic abnormal development of the lymphatic system. Sometimes they may be associated with other vascular malformations (venous or arterial)1,2. ML usually appear at birth, in early childhood or during the first years of life (congenital vs. acquired) and are mainly localized in the region of the head and neck, a...

View All Clinical Trials